Paper Details

  1. Home
  2. Paper Details

Long-Term Dexmedetomidine Use and Safety Profile in Palliative Care: A Case Report.

Author: Dieudonné RahmNathalie, KemichaTijani, PapasokratiLida, PautexSophie

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Dexmedetomidine infusion, added to hydromorphone, was successfully used for two months in a patient with intractable cancer pain, restlessness, sleep disorder, anxiety, and craving symptoms. Long-term conscious sedation with IV dexmedetomidine was well tolerated, offering a potential therapeutic option for palliative patients with severe symptoms.
Paper Details　
Original Abstract of the Article :
There is a lack of report of conscious sedation used as a last resort therapy for alleviating severe symptoms. To achieve this goal, dexmedetomidine appears to be a promising option. We report a case of successful two-month long treatment of intravenous (IV) dexmedetomidine added to hydromorphone fo...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1089/jpm.2022.0496

データ提供：米国国立医学図書館（NLM）

Dexmedetomidine: A Beacon of Hope in Palliative Care

The desert of palliative care often presents a challenging landscape, with patients facing debilitating pain, anxiety, and discomfort. This case report sheds light on the use of dexmedetomidine, a medication traditionally used for sedation, as a potential treatment option for alleviating severe symptoms in palliative care. The researchers explored the feasibility and safety of long-term dexmedetomidine use for a patient with intractable cancer pain and other distressing symptoms.

Dexmedetomidine: A Potential Oasis in Palliative Care

The case report demonstrated the successful use of dexmedetomidine to manage intractable pain, restlessness, sleep disturbance, anxiety, and craving symptoms in a palliative care patient. This suggests that dexmedetomidine may offer a viable alternative for managing challenging symptoms in end-of-life care.

Navigating the Desert of End-of-Life Care

This research highlights the need for innovative approaches to managing symptoms in palliative care, focusing on comfort, dignity, and symptom relief. It underscores the importance of exploring new and effective treatment options to improve the quality of life for individuals facing serious illness.

Dr.Camel's Conclusion

This case report is a ray of hope in the vast desert of palliative care. It shows that dexmedetomidine, a medication traditionally used for sedation, may be a valuable tool for managing intractable symptoms in end-of-life care. This research is a reminder of the importance of exploring new and effective treatment options to improve the quality of life for individuals facing serious illness.

Date :
  1. Date Completed 2023-06-07
  2. Date Revised 2023-06-24
Further Info :

Pubmed ID

36603112

DOI: Digital Object Identifier

10.1089/jpm.2022.0496

Related Literature

Article Analysis
・Side Effects of hydromorphone
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.